Orion Biotechnology Canada Announces Partnership with Nanjing University

Orion Biotechnology Canada Ltd, an Ottawa-headquartered developer of medical treatments for chronic illness and life-threatening diseases, has announced a strategic partnership with the Center for Public Health Research (CPHR) and the State Key Laboratory of Analytical Chemistry (SKLAC) of Nanjing University. The partnership will focus on supporting the development of Orion’s China-sourced biopharmaceutical solutions, including the company’s unique multipurpose microbicide candidate designed to be a contraceptive which also prevents the transmission of HIV. Nanjing University’s SKLAC and CPHR will collaborate with Orion in conducting research and development, pre-clinical testing and studies.

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.